Skip to Main Content

Author Details

Douglas A Levine
Perlmutter Cancer Center
1999
259
76
PMIDPaper TitleJournal TitlePublished Year
37707822Remotely Delivered Cancer Genetic Testing in the Making Genetic Testing Accessible (MAGENTA) Trial: A Randomized Clinical Trial.JAMA Oncol2023
37707822Remotely Delivered Cancer Genetic Testing in the Making Genetic Testing Accessible (MAGENTA) Trial: A Randomized Clinical Trial.JAMA Oncol2023
34906376Impact of homologous recombination status and responses with veliparib combined with first-line chemotherapy in ovarian cancer in the Phase 3 VELIA/GOG-3005 study.Gynecol Oncol2022
36251350An Accessible Communication System for Population-Based Genetic Testing: Development and Usability Study.JMIR Form Res2022
35949654The congressionally directed medical research programs' Ovarian Cancer Academy: a new approach to training in biomedical research.J Clin Transl Sci2022
36155347Using Social Media to Facilitate Communication About Women's Testing: Tool Validation Study.JMIR Form Res2022
36150916The role of CTNNB1 mutations and matrix metalloproteinases (MMPs) in anti-angiogenesis treatment of endometrial carcinoma.Gynecol Oncol2022
36077735Molecular Analysis of Short- versus Long-Term Survivors of High-Grade Serous Ovarian Carcinoma.Cancers (Basel)2022
34906376Impact of homologous recombination status and responses with veliparib combined with first-line chemotherapy in ovarian cancer in the Phase 3 VELIA/GOG-3005 study.Gynecol Oncol2022
36150916The role of CTNNB1 mutations and matrix metalloproteinases (MMPs) in anti-angiogenesis treatment of endometrial carcinoma.Gynecol Oncol2022
35949654The congressionally directed medical research programs' Ovarian Cancer Academy: a new approach to training in biomedical research.J Clin Transl Sci2022
36155347Using Social Media to Facilitate Communication About Women's Testing: Tool Validation Study.JMIR Form Res2022
36251350An Accessible Communication System for Population-Based Genetic Testing: Development and Usability Study.JMIR Form Res2022
36077735Molecular Analysis of Short- versus Long-Term Survivors of High-Grade Serous Ovarian Carcinoma.Cancers (Basel)2022
32546565Population-based targeted sequencing of 54 candidate genes identifies <i>PALB2</i> as a susceptibility gene for high-grade serous ovarian cancer.J Med Genet2021
33541735Mutated p53 portends improvement in outcomes when bevacizumab is combined with chemotherapy in advanced/recurrent endometrial cancer: An NRG Oncology study.Gynecol Oncol2021
33793971Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta-analysis.Cancer2021
34161278Computational modeling of ovarian cancer dynamics suggests optimal strategies for therapy and screening.Proc Natl Acad Sci U S A2021
34037709Joint IARC/NCI International Cancer Seminar Series Report: expert consensus on future directions for ovarian carcinoma research.Carcinogenesis2021
34030871Uterine carcinosarcomas: From pathology to practice.Gynecol Oncol2021
32546565Population-based targeted sequencing of 54 candidate genes identifies <i>PALB2</i> as a susceptibility gene for high-grade serous ovarian cancer.J Med Genet2021
33375990Angiogenesis in endometrial carcinoma: Therapies and biomarkers, current options, and future perspectives.Gynecol Oncol2021
33158842Genetically Defined, Syngeneic Organoid Platform for Developing Combination Therapies for Ovarian Cancer.Cancer Discov2021
34797711A perception-based nanosensor platform to detect cancer biomarkers.Sci Adv2021
34485660<i>CCNE1</i> amplification among metastatic sites in patients with gynecologic high-grade serous carcinoma.Gynecol Oncol Rep2021
33793971Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta-analysis.Cancer2021
33541735Mutated p53 portends improvement in outcomes when bevacizumab is combined with chemotherapy in advanced/recurrent endometrial cancer: An NRG Oncology study.Gynecol Oncol2021
34485660<i>CCNE1</i> amplification among metastatic sites in patients with gynecologic high-grade serous carcinoma.Gynecol Oncol Rep2021
34797711A perception-based nanosensor platform to detect cancer biomarkers.Sci Adv2021
34161278Computational modeling of ovarian cancer dynamics suggests optimal strategies for therapy and screening.Proc Natl Acad Sci U S A2021
34037709Joint IARC/NCI International Cancer Seminar Series Report: expert consensus on future directions for ovarian carcinoma research.Carcinogenesis2021
34030871Uterine carcinosarcomas: From pathology to practice.Gynecol Oncol2021
33375990Angiogenesis in endometrial carcinoma: Therapies and biomarkers, current options, and future perspectives.Gynecol Oncol2021
33158842Genetically Defined, Syngeneic Organoid Platform for Developing Combination Therapies for Ovarian Cancer.Cancer Discov2021
32322030A catalogue of cancer-driving mutations in healthy tissue.Nature2020
32322030A catalogue of cancer-driving mutations in healthy tissue.Nature2020
32057464Facilitated referral pathway for genetic testing at the time of ovarian cancer diagnosis: uptake of genetic counseling and testing and impact on patient-reported stress, anxiety and depression.Gynecol Oncol2020
31986064Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline.J Clin Oncol2020
32473302Prognostic gene expression signature for high-grade serous ovarian cancer.Ann Oncol2020
32839026State of the science: Uterine sarcomas: From pathology to practice.Gynecol Oncol2020
33212885Integrated Multi-Tumor Radio-Genomic Marker of Outcomes in Patients with High Serous Ovarian Carcinoma.Cancers (Basel)2020
32057464Facilitated referral pathway for genetic testing at the time of ovarian cancer diagnosis: uptake of genetic counseling and testing and impact on patient-reported stress, anxiety and depression.Gynecol Oncol2020
31986064Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline.J Clin Oncol2020
33212885Integrated Multi-Tumor Radio-Genomic Marker of Outcomes in Patients with High Serous Ovarian Carcinoma.Cancers (Basel)2020
32839026State of the science: Uterine sarcomas: From pathology to practice.Gynecol Oncol2020
32473302Prognostic gene expression signature for high-grade serous ovarian cancer.Ann Oncol2020
30683880Shared heritability and functional enrichment across six solid cancers.Nat Commun2019
31772167Both fallopian tube and ovarian surface epithelium are cells-of-origin for high-grade serous ovarian carcinoma.Nat Commun2019
31554806Chromatin-informed inference of transcriptional programs in gynecologic and basal breast cancers.Nat Commun2019
31703812Comprehensive genomic sequencing of paired ovarian cancers reveals discordance in genes that determine clinical trial eligibility.Gynecol Oncol2019
  • 1 - 50 of 518

Recommended Authors

Pier Selenica
Memorial Sloan Kettering Cancer Center
Career Start Year 2017
Number of shared co-authors 33
Arnaud Da Cruz Paula
Memorial Sloan Kettering Cancer Center
Career Start Year 2014
Number of shared co-authors 24
Cathleen Matrai
Weill Cornell Medical Center
Career Start Year 2013
Number of shared co-authors 3
George Au-Yeung
The University of Melbourne
Career Start Year 2012
Number of shared co-authors 33
Ghassan Allo
Henry Ford Hospital
Career Start Year 2011
Number of shared co-authors 14
Eloise Chapman-Davis
Weill Cornell Medical College
Career Start Year 2009
Number of shared co-authors 2
Ruby Yun-Ju Huang
National Taiwan University College of Medicine
Career Start Year 2008
Number of shared co-authors 112
Myriam Kossai
INSERM, Universite Clermont Auvergne
Career Start Year 2008
Number of shared co-authors 4
Yingmei Wang
Tianjin Medical University General Hospital
Career Start Year 2007
Number of shared co-authors 7
Shin-Wha Lee
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 2006
Number of shared co-authors 1
Divya Gupta
Emory University School of Medicine
Career Start Year 2006
Number of shared co-authors 3
Donal J Brennan
National Centre for Peritoneal Malignancy, Mater Misericordiae University Hospital
Career Start Year 2005
Number of shared co-authors 35
Tuan Zea Tan
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2005
Number of shared co-authors 113
Andrew H Beck
Beth Israel Deaconess Medical Center, Harvard Medical School
Career Start Year 2004
Number of shared co-authors 67
Leah M Prentice
British Columbia Women's Hospital and Health Centre
Career Start Year 2004
Number of shared co-authors 42
Peter Horak
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Career Start Year 2003
Number of shared co-authors 6
Maria Del Pilar Estevez Diz
Instituto do Cancer do Estado de Sao Paulo and Universidade de Sao Paulo
Career Start Year 2002
Number of shared co-authors 1
Saravut J Weroha
Mayo Clinic
Career Start Year 2001
Number of shared co-authors 24
Steve E Kalloger
University of British Columbia
Career Start Year 2000
Number of shared co-authors 38
Aparna A Kamat
Houston Methodist Hospital
Career Start Year 2000
Number of shared co-authors 6
Susan C Modesitt
University of Virginia, Emily Couric Clinical Cancer Center
Career Start Year 1998
Number of shared co-authors 7
Ingrid Hedenfalk
Lund University and Skane University Hospital
Career Start Year 1997
Number of shared co-authors 12
Paulette Mhawech-Fauceglia
University of Southern California
Career Start Year 1995
Number of shared co-authors 19
Yong-Man Kim
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 1994
Number of shared co-authors 2
Denise C Connolly
Fox Chase Cancer Center
Career Start Year 1993
Number of shared co-authors 12
Rosemarie Schmandt
The University of Texas MD Anderson Cancer Center, UT MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 12
Funda Meric-Bernstam
University of Texas MD Anderson Cancer Center
Career Start Year 1990
Number of shared co-authors 43
Lora H Ellenson
Memorial Sloan Kettering Cancer Center
Career Start Year 1989
Number of shared co-authors 16
Jos?? Palacios
Universidad de Alcala
Career Start Year 1983
Number of shared co-authors 137
Jeffrey S Ross
Foundation Medicine
Career Start Year 1974
Number of shared co-authors 14

Collaborators

Andrew Berchuck
Duke School of Medicine
Co-authored papers 53
Beth Y Karlan
David Geffen School of Medicine, University of California los angeles
Co-authored papers 52
Marc T Goodman
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 50
Ellen L Goode
Mayo Clinic College of Medicine
Co-authored papers 50
Paul D P Pharoah
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers 49
Susan J Ramus
School of Clinical Medicine, University of NSW Sydney, Lowy Cancer Research Centre
Co-authored papers 48
Mary Anne Rossing
Fred Hutchinson Cancer Research Center
Co-authored papers 47
Anna H Wu
University of Southern California
Co-authored papers 47
Simon A Gayther
Cedars-Sinai Medical Center
Co-authored papers 47
Jennifer A Doherty
Huntsman Cancer Institute, University of Utah
Co-authored papers 46
Usha Menon
College of Nursing, University of South Florida
Co-authored papers 46
Honglin Song
University of Cambridge
Co-authored papers 46
Joellen M Schildkraut
Rollins School of Public Health, Emory University
Co-authored papers 45
Hoda Anton-Culver
University of California irvine
Co-authored papers 45
Nicolas Wentzensen
National Cancer Institute, National Institutes of Health
Co-authored papers 44
Celeste Leigh Pearce
University of Michigan School of Public Health ann arbor
Co-authored papers 44
Jacek Gronwald
International Hereditary Cancer Center, Pomeranian Medical University
Co-authored papers 44
Peter A Fasching
Otto-Friedrich-University Bamberg
Co-authored papers 43
Weiva Sieh
Co-authored papers 43
Jenny Chang-Claude
German Cancer Research Center (DKFZ)
Co-authored papers 42
Aleksandra Gentry-Maharaj
UCL EGA Institute for Women's Health, University College London
Co-authored papers 42
Diether Lambrechts
Co-authored papers 42
Ian G Campbell
Co-authored papers 42
Georgia Chenevix-Trench
QIMR Berghofer Medical Research Institute
Co-authored papers 41
Elisa V Bandera
Co-authored papers 41
Jan Lubinski
Pomeranian Medical University
Co-authored papers 41
Alice S Whittemore
Co-authored papers 40
Brooke L Fridley
H. Lee Moffitt Cancer Center and Research Institute
Co-authored papers 40
Jonathan Tyrer
Co-authored papers 40
Tanja Pejovic
Oregon Health & Science University
Co-authored papers 39
Release 1.2